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WHO   WORLD HEALTH ORGANISATION 
IDA   IRON DEFICIENCY ANEMIA 
UNICEF  UNITED NATIONS CHILDREN’S FUND 
UNU   UNITED NATIONS UNIVERSITY 
HIV   HUMAN IMMUNO DEFICIENCY VIRUS 
AIDS   AUTO-IMMUNE DEFICIENCY SYNDROME 
MMR  MATERNAL MORTALITY RATIO 
G6PD  GLUCOSE 6 PHOSPHATE DEHYDROGENASE 
CFU-E  COLONY FORMING UNIT-ERYTHROCYTES 
GIT   GASTROINTESTINAL TRACT 
CBC   COMPLETE BLOOD COUNT 
Hb   HEMOGLOBIN 
LFT   LIVER FUNCTION TEST 
RFT   RENAL FUNCTION TEST 
ESR   ERYTHROCYTE  SEDIMENTATION RATE 
CRP   C-REACTIVE PROTEIN 
 
 
BMI   BODY MASS INDEX  
Hb1AC  GLYCOSYLATED HEMOGLOBIN 
T2DM  TYPE 2 DIABETES MELLITUS 
EDTA  ETHYLENE DIAMINE TETRA-ACETIC ACID 
TC   TOTAL COUNT 
RBC   RED BLOOD CELLS 
MCV   MEAN CORPUSCULAR VOLUME 
MCH   MEAN CELL HEMOGLOBIN 
MCHC MEAN CORPUSCULAR HEMOGLOBIN         
CONCENTRATION  
RDW   RED CELL DISTRIBUTION WIDTH 
SD   STANDARD DEVIATION 










BACKGROUND: Anaemia is a major public health problem in India. 
According to WHO, there are two billion people with anaemia in the world and half 
of the anaemia is due to iron deficiency. The prevalence of anaemia is 
disproportionately high in developing countries like India which attributes to poverty, 
inadequate diet, certain diseases, pregnancy and lactation, and poor access to health 
services. Nutritional anaemia constitutes the most important cause of anaemia. The 
purpose of this study was to study the laboratory profile of patients with anemia and 
to study the hematological types of anemia in such patients as well as the closest 
possible etiological profile.  
 
Objectives:  
To study the prevalence of anaemia and its aetiology in patients attending  
Sree Mookambika Institute Of Medical Sciences and to study  the proportion of 
patients with nutritional anaemia. 
Materials and methods:  
A cross sectional study was done in a tertiary health care hospital in 
kanyakumari district ,SREE MOOKAMBIKA INSTITUTE OF MEDICAL 
SCIENCES.A total of 160 patients who came to medicine department of the same 
who fulfilled our inclusion criteria were included in the study.The study took place for 
a period of 18 months.Statasticial analysis was done using percentage,standard error 















































































Anemia is a serious global public health problem affecting both developing 
and developed countries having an impact on human health as well as social and 
economic development. It occurs at all stages of the life, but is more common in 
pregnant women and young children. Globally, over 3.5 billion people, more than half 
the world’s population, are affected by iron deficiency in the year 2014 as compared 
to 1.62 billion people in the year 2008. Prevalence of iron deficiency in developing 
countries are staggering (44% of women, 42% of preschoolers, 53% of school-aged 
children and 33% of men), with Asia and Africa having the highest prevalence 1 
 In 2014, prevalence of nutritional anemia among adolescent girls was found 
to be high (47.6% to 90%) in different parts of in North India and the prevalence 
found to be (78.7%) in the state of TamilNadu2. 
In 1992, World Health Organization global estimates of anemia prevalence averaged 
56%, with a range of 35–75% depending on geographic location World Health 
Organisation 19923.  
The third National Family Health Survey (NFHS) 2005–2006 revealed that at 
least 80% of Indian children aged 12 to 23 months were anemic4. Anemia was 
especially prevalent among rural children, and the majority of India's population 
(72.2%) is rural. However, despite recent economic development and the existence of 
a national anemia-control program, the prevalence of anemia in India between 2000 




Infants and young children having high risk to develop iron deficiency due to higher 
requirements of iron for their rapid growth9. Iron deficiency is the primary cause for 
anemia in children. 
ETIOLOGY 
 NUTRITIONAL ANEMIA  
Nutritional Anemia was defined (WHO)as “a condition in which the 
hemoglobin content of the blood is lower than normal as a result of a deficiency of 
one or more essential nutrients, regardless of the cause of such deficiency.”10 
 
• IRON DEFICIENCY  
Iron deficiency is the most common preventable nutritional problem despite 
continued global goals for its control. Globally, the most significant contributor to the 
onset of anaemia is iron deficiency so that iron deficiency anemia and anaemia are 
often used synonymously, and the prevalence of anaemia has often been used as a 
proxy for iron deficiency anemia. It is generally assumed that 50% of the cases of 
anaemia are due to iron deficiency(IDA).11 
The singular importance of iron deficiency was restated with more confidence 
by Baker and DeMaeyer: “The major factor responsible [for nutritional anemia] is a 
deficiency of iron, with folate deficiency also playing a role in some population 
groups, especially in pregnant women.” 
Anemia was considered an indicator of iron deficiency rather than iron 
deficiency being considered a contributing cause of anemia (WHO/UNICEF/ UNU, 




Hook worm infestations, HIV / AIDS, malaria, chronic infections also results in Iron 
deficiency anemia12. 
Worm infestation is a major public health problem in children of developing 
countries because of poor socioeconomic conditions and lack of good hygienic living. 
It causes nutritional deficiencies and anaemia13. 
 
• OTHER CAUSES OF NUTRITIONAL ANEMIAS 
¾ deficiency of folic acid, vitamin B12 (megaloblastic anemias)14.  
 
 INHERITED DISORDERS OF HAEMOGLOBIN 
Of the large group of anemias due to inherited disorders, Thalassemias, 
particularly major disease of beta thalassemia are a considerable health problem in 
india and contribute significantly to mortality and morbidity with its increasing 
prevalence. 
 
 ANEMIAS OF CHRONIC DISEASE 
The most common chronic diseases associated with development of anemia are 
chronic kidney disease and chronic liver failure. 
 
AGE GROUPS AFFECTED 
Anemia is a common condition. It occurs in all age, racial, and ethnic groups.  
Among children, female children were more susceptible to anemia and undernutrition 




Among adolescents, girls constitute a vulnerable group, particularly in 
developing countries where they are traditionally married at an early age and exposed 
to a greater risk of reproductive morbidity and mortality. The nutritional anemia in 
this group attributes to high MMR, high incidence of low-birth weight babies, high 
perinatal mortality and fetal wastage and consequent high fertility rates. Also can be 
attributed to lack of education, and sanitation.15 
Among adults, both men and women can have anemia. From teenage to 
socially active and productive age groups of population, anemia is almost exclusively 
prevalent in females. Especially, women of childbearing age are at higher risk for the 
condition.16 
  Estimates of anemia prevalence among the elderly range from 2.9% to 61% in 
elderly men and from 3.3% to 41% in elderly women17. Most anemia in older 
individuals results from iron deficiency, chronic inflammation, or chronic kidney 
disease, or it may be unexplained18. 
EFFECTS ON HEALTH 
 Effects on pregnancy 
Severe anemia during pregnancy is associated with a woman’s increased risk of death 
and moderate to severe anemia is associated with an increased risk of low birth weight 
and preterm delivery 
 Effects on growth and development 
Anemia may compromise pubertal growth spurt. It may also reduce physical work 
capacity and cognitive function. 




 Effects on elderly age group 
Anemia in older individuals is associated with a very wide range of complications 
such as,  
1. increased risk for mortality,  
2. cardiovascular disease,  
3. cognitive dysfunction,  
4. longer hospitalization for elective procedures and comorbid conditions, 
5.  reduced bone density, and falls and fractures.  
6. Not surprisingly, anemia also has a significant effect on quality of life (QOL) in the 
elderly.  
SOCIOECONOMIC FACTORS 
Status of literacy and wealth of parents have strong negative association with the 
status of anemia of the children. The most vulnerable groups are the children of 
illiterate parents, maternal anemia, and those belonging to the poor families in the 
rural areas. 
 Economically deprived women having multiple, closely spaced pregnancies are at 
exceptionally high risk of developing anemia. 
SCIENTIFIC JUSTIFICATION OF THE STUDY 
Anemia is a common concern in older people ,females and children with 
associated risk factors  and can have significant morbidity and mortality. Because 
anemia is a sign, not a diagnosis, an evaluation is almost always needed  to identify 
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α is hydroxylated and degraded. If O2 supply becomes impaired, the critical 
hydroxylation step does not occur, thus HIF- l α  partner with other proteins and get 
translocated to the nucleus and upregulate the expression of the Erythropoietin gene 
and production of erythrocytes. Thus the process of hematopoiesis requires normal 
renal production of Erythropoietin, a functioning erythroid bone marrow for it to act, 
and adequate supply of substrates for the synthesis of hemoglobin. A defect in any 
one of the key components can lead to anemia.20 
                                     HEMATOPOIETIC STEM CELLS 
 
                                            PROERYTHROBLASTS                                                    
   ERYTHROPOIETIN 
                                          RED BLOOD CELLS 
     Decreases                                              
                                          TISSUE OXYGENATION                            
 
     DECREASES 
 
FACTORS THAT DECREASE OXYGENATION 
1) LOW BLOOD VOLUME 
2) ANEMIA 
3) LOW HEMOGLOBIN 
4) POOR BLOOD FLOW 
5) PULMONARY DISESASE 
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  The production of different types of blood cells which includes formation, 
development, and differentiation of blood cells is called hematopoiesis and red cell 
production is called erythropoiesis.21 The first cell that belongs to the erythroid series 
is the proerythroblast, Once the proerythroblast is formed, it divides multiple times, 
eventually forms many mature red blood cells. The proerythroblast is followed by 
cells called basophil erythroblasts, succeeding generations are polychromatophil 
erythroblast, orthochromatic erythroblast, reticulocytes and erythrocytes . During the 
reticulocyte stage, the cells pass from the bone marrow into the blood capillaries by a 
process called diapedesis (squeezing through pores of the capillary membranes). The 
basophilic material contained in the reticulocyte will normally disappear within 1 to 2 
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days, and the cell is then known as mature erythrocyte. The reticulocyte maturation 
time is a variable who’s prolongation indicates the severity of anemia.22 
 
FORMATION OF HEMOGLOBIN 
 
Hemoglobin is made of four protein molecules known as globulin chains that 
are joined together. The normal adult hemoglobin abbreviated as HbA contains two 
alpha globulin chains and two beta globulin chains. Synthesis of hemoglobin begins 
in the proerythroblasts stage and ends in the reticulocyte stage. First, succinyl-CoA, 
from the Krebs cycle binds with the glycine molecule to form a pyrrole molecule. 
Four pyrroles molecules in turn combine to form protoporphyrin IX, which then joins 
with iron to form what is called the heme molecule. Finally, each heme molecule 
combines with a globin chain that are synthesized by ribosomes to form a hemoglobin 
chain. The four different types of hemoglobin chains are alpha chains, beta chains, 
gamma chains, and delta chains.23 
ANEMIA 
 
By definition, Anemia is defined as the reduction in the total circulating 
red cell mass below normal limits for the age and sex. Anemia decreases the 
oxygen-carrying capacity of the red blood cells, leading to tissue hypoxemia. Anemia 
is also defined as a reduction in the hemoglobin concentration of the blood, to the 
levels below the normal limits for the age and sex.24 
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The classification of anemia has been unsatisfactory till date. Attempts has been made 
to classify anemias according to the etiology involved, morphology, and severity. The 
different classifications of anemia are:25 
 
 Morphologic characters include : 
(a) red cell size (normocytic, microcytic, or macrocytic);  
(b) degree of hemoglobinization, reflected in the color of red cells (normochromic or 
hypochromic). 
These provide etiologic clues for the cause of anemia. 
 
The above classification is based on the Red cell indices which are as follows: 
• Mean cell volume: the average volume of a red cell (fL) 
• Mean cell hemoglobin: the average amount of hemoglobin per red cell,  in 
pictograms(pg). 
• Mean cell hemoglobin concentration: the concentration of hemoglobin in a given 
volume of packed red cells, expressed as grams per deciliter(dL). 














Any value below the recommended WHO criteria is anemia. Adult reference ranges 
for red cell indices are as follows26 
 
MEASUREMENT(units) MEN WOMEN 
HEMOGLOBIN(gm/dL) 13.6-17.2 12.0-15.0 
HEMATOCRIT(%) 39-49 33-43 
RED CELL COUNT(x 106/µL) 4.3-5.9 3.5-5.0 
RETICULOCYTE COUNT (%) 0.5-1.5  
MEAN CELL VOLUME(fL) 82-96  
MEAN CELL HEMOGLOBIN(pg) 27-33  
MEAN CELL HEMOGLOBIN 
CONCENTRATION(gm/dL) 
33-37  
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 Anemias can also be classified based on the underlying mechanism / etiology by 
which it develops. 
 These are divided into three main groups27:  
• Anemia caused due to blood loss 
• Anemia caused due to decreased or faulty red blood cell production 
• Anemia caused due to destruction of red blood cells  
CLASSIFICATION OF ANEMIAS: 









1. ACUTE BLOOD LOSS 
2. CHRONIC BLOOD LOSS 














INHERITED GENETIC DEFECTS 
1. RED CELL MEMBRANE 
DISORDERS 
2. ENZYME DEFICIECY 
• HEXOSE MONOPHOSPHATE 
SHUNT ENZYME DEFICIENCIES 
• GLYCOLYTIC ENZYME 
DEFICIENCIES 
































1. DEFICIENT GLOBIN SYNTHESIS 
2. STRUCTURALLY ABNORMAL 
GLOBINS(HEMOGLOBINOPATHI
ES) 
AQUIRED GENETIC DEFECTS 








2. CARDIAC TRAUMATIC 
HEMOLYSIS 
3. REPETETIVE PHYSICAL 
TRAUMA 
 
INFECTIONS OF RED CELLS 
TOXIC OR CHEMICAL INJURY 
MEMBRANE LIPID ABNORMALITIES 




DECREASED RED CELL 
PRODUCTION 
 
INHERITED GENETIC DEFECTS 
1. DEFECTS LEADING TO STEM 
CELL DEPLETION 









B12 and folate deficiencies 
 
 
Iron deficiency anemia 
 




Aplastic anemia,pure red 
cell aplasia 
 













IMMUNE MEDIATED INJURY OF 
PROGENITORS 




SPACE OCCUPYIING MARROW 
LESIONS 
 
INFECTIONS OF RED CELL 
POGENITORS 
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Pallor, Weakness, malaise, and easy fatigability are the usual complaints. The 
low oxygen supply by the circulating blood leads to dyspnea on mild exertion. Fatty 
change in the liver, myocardium, and kidney is caused by hypoxia. 
The most serious complications of severe anemia arise due to tissue hypoxia. 
Shock, hypotension, or coronary and pulmonary insufficiency can occur. This is more 
common in older individuals with underlying pulmonary insufficiency and 
cardiovascular disease. Sufficiently severe fatty changes in the myocardium are, leads 
to cardiac failure and compound the tissue hypoxia caused by the deficiency of O2 in 
the blood. The myocardial Hypoxia also can manifests as angina, particularly when 
complicated by pre-existing coronary artery disease28. With acute blood loss and 
shock, oliguria and anuria can develop as a result of renal hypoperfusion. Central 
nervous system hypoxia can cause headache, dimness of vision, and faintness. 
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ACUTE BLOOD LOSS 
The effects of acute blood loss are mainly due to the loss of intravascular 
volume, which leads to reduction in oxygenation of tissues. This reduction in 
oxygenation leads to increase in secretion of erythropoietin from the kidney, 
stimulating the proliferation of erythrocytes (CFU-E) in the marrow and which appear 
as reticulocytes in the peripheral blood (known as reticulocytosis) but  the change in 
hematocrit value after hemorrhage usually occurs slowly. And also during the 
bleeding episodes, there is a rapid increase in the numbers of circulating leukocytes 
and platelets.29  
HEMOLYTIC ANEMIAS 
Hemolytic anemias are defined as anemias resulting from an increase in red 
cell destruction. Normally red cell undergo destruction at the end of their life span of 
120 days within the reticuloendothelial (RE) system cells, such as spleen and 
extravascular hemolysis, and hemoglobin is not liberated into the plasma in 
appreciable amounts. Hemolytic anemia presents as acute or chronic anemia, 
reticulocytosis, or jaundice. 
Hemolytic anemias has the following features: 
i. A shortened red cell life span below the normal 120 days. 
ii. Elevated erythropoietin levels and a compensatory increase in erythropoiesis. 
iii. Accumulation of hemoglobin degradation products that are produced during the 
process of red cell hemolysis. 
There are two types of hemolytic anemia: Extravascular hemolysis and intravascular 
hemolysis. 
Review of Literature   
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The more common extravascular hemolysis is the destruction of red blood 
cells within the macrophages of the spleen and liver. The triad of symptoms of 
extravascular hemolysis: anemia, splenomegaly, and jaundice. 
 
Intravascular hemolysis is the destruction of red blood cells in the circulatory 
system with the release of the contents  of red cell into the plasma, caused by 
mechanical injury, complement fixation, intracellular parasites (e.g., falciparum 
malaria), or exogenous toxins. 30 
 
Intravascular hemolysis is manifested as anemia, hemoglobinemia, 
hemoglobinuria, hemosiderinuria,and jaundice. Unlike extravascular hemolysis, 
splenomegaly is not a feature. 
 
TYPES OF EXTRAVASCULAR HEMOLYSIS 
 
1) Hereditary Spherocytosis 
In Hereditary spherocytosis the primary defect in hereditary spherocytosis is 
the loss of membrane surface area due to defects in the membrane proteins ankyrin, 
band 3, β spectrin, α spectrin, leading to reduced deformability and vulnerability to 
splenic sequestration and destruction. HS is caused by diverse mutations that leads to 
an insufficiency in the membrane skeletal components.31 
 
2) Hemolytic Disease Due to Red Cell Enzyme Defects: 
Abnormalities in the hexose monophosphate (HMP) shunt or glutathione 
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5) Paroxysmal Nocturnal Hemoglobinuria 
Paroxysmal nocturnal hemoglobinuria (PNH) is a disorder of the 
hematopoietic stem cell resulting in the clonal production of blood cells which are 
defective in the surface proteins called glycan-phosphatidylinositol (GPI)-linked 
surface proteins and are abnormally susceptible to lysis or injury by complement35. 
 
6) Immunohemolytic Anemias 
Hemolytic anemia is caused by antibodies that identify and bind to red cells 
antigen, leading to their premature destruction. These disorders are commonly 
referred to as autoimmune hemolytic anemias. 
WARM ANTIBODY TYPE(IgG ANTIBODIES ACTIVE AT 370C) 
• PRIMARY(IDIOPATHIC) 
• SECONDARY 
i. Auto immune disorders(particularly systemic lupus erythematosus) 
ii. Drugs 
iii. Lymphoid neoplasms 





ii. Lymphoid neoplasms 
COLD HEMOLYSIN TYPE(IgG ANTIBODIES ACTIVE BELOW 
370C) 
Rare;occurs mainly in childer following viral infections 
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Warm agglutinin type autoantibodies of autoimmune hemolytic anemia are usually 
IgG, but can also be IgM or IgA that are active at 37 0 C. They are usually Rh 
specific. Cold-type antibodies are both IgM or IgG known as Donath-Landsteiner 
[DL] antibodies. 36 
 
TYPES OF INTRAVASCULAR HEMOLYSIS 
 
1) Hemolytic Anemia Resulting from Trauma to Red Cells: 
 The shear forces produced by the turbulence of blood flow and the pressure 
gradients across damaged valves or lumen narrowing causes hemolysis. Causes of 
mechanical injury such as trauma caused by blood flow across the cardiac valves, 
thrombotic narrowing of the microcirculation, or repeated physical trauma (e.g., 
marathon running). 
2) Complement fixation 
 Complement fixation occurs in many of the situations in which antibodies 
recognize and bind to the red cell antigens. 
3) Exogenous toxic factors 
Toxic injury due to Clostridial sepsis, causes massive hemolysis and leads to 
anemia.37 
 
ANEMIAS OF DIMINISHED ERYTHROPOIESIS 
 
The most commonest and important group of anemias associated with red cell 
underproduction are those due to nutritional deficiencies, followed by those that arise 
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 (3) increased requirement by the body, 
 (4) chronic blood loss such as gastric blled in APD. 
Nutritional iron deficiency arises when the physiological requirements cannot 
be met by the iron absorption from diet. 
Impaired absorption is found in sprue, other causes are gastrectomy, fat malabsorption 
(steatorrhea), and chronic diarrhea. 
Increased requirement is an important cause of iron deficiency in growing 
infants, children, and adolescents, as well as premenopausal women, particularly 
during pregnancy. 
Chronic blood loss such as External hemorrhage or chronic bleeding into the 
gastrointestinal tract, genitourinary tracts, depletes the iron stores. Iron deficiency 
anemia produces a microcytic hypochromic type of blood picture.40 
 
CLINICAL FEATURES SPECIFIC TO IRON DEFICIENCY 
 
In severe and long-standing iron deficiency, depletion of iron-containing 
enzymes in cells throughout the body also causes other changes, including 
koilonychia, alopecia, atrophic changes in the tongue and gastric mucosa, and 
intestinal malabsorption. In the brain, iron is bound to ferritin, the levels of which are 
decreased by iron deficiency and increased by iron supplementation. A Low ferritin 
levels in childhood have been reported to affect the development of the nervous 









The megaloblastic anemia causes impairment of DNA synthesis that leads to 
ineffective hematopoiesis and distinctive morphologic changes, including abnormally 
large erythroid precursors and red cells. The spectrum of etiologies associated with 
macrocytic anemia includes nutritional deficiencies (e.g: vitamin B12 and folate), 
drugs (eg: methotrexate), primary bone marrow disorders (e.g: myelodysplasia and 
leukemia) and other chronic illnesses. Macrocytic morphology due to vitamin B12 
deficiency and folate deficiency is a direct result of ineffective or dysplastic 
erythropoiesis.42 
 
ANEMIA OF CHRONIC DISEASE 
 
Anemia of chronic disease may be secondary to infections, autoimmune 
disorders, chronic renal failure, or malignancies. It is characterized by an immune 
activation with an increase in inflammatory cytokines and resultant increase in 
hepcidin levels. Inappropriate erythropoietin levels or hyporesponsiveness to 





Aplastic anemia is a group of disorders characterized by pancytopenia, 
variable bone-marrow hypocellularity, and the absence of underlying malignant or 
myeloproliferative disease. Due to diverse causes, such as exposures to toxins and 
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radiation, reactions to drugs and viruses, and inherited defects in telomerase and DNA 
repair.44 
Causes of Pure red cell aplasia: 
 
• Acute: due to Parvovirus B19 infection (may persist in immunosuppressedpatients) 
• Chronic: Associated with thymoma, large granular lymphocytic leukemia, 




Initially a complete blood count (CBC) is performed and the values evaluated. 
Further evaluation will depend on the altered parameters in CBC. Hb value is low 
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cause. Once the cause has been ascertained, oral iron therapy is commonly prescribed 
to the patient to correct the iron deficiency. The treatment of iron deficiency should 
always start with oral iron, both to correct anemia as well as to replenish the body 
stores. When this fails because of conditions such as large blood losses, iron 
malabsorption, or intolerance to oral iron, parenteral iron can be prescribed using iron 
dextran, iron gluconate or iron sucrose.  Parenteral iron therapy is necessary for 
patients with intolerance or unresponsiveness to oral iron therapy. Blood transfusions 
is reserved for patients with or who are at risk of cardiovascular instability due to their 
degree of anemia. The ultimate goal in the management of anemia is to correct 
anemia, maintain the iron status parameters within the recommended levels and to 
improve the patient survival rate.45 
Latest studies have revealed that, Erythropoietin combined with parenteral 
iron is an effective treatment for moderate and severe iron deficiency anemia, with 
minimal adverse or side effects. It is an effective alternative to blood transfusion, or 
may be used in cases of resistant anemia that are not been effectively treated by iron 
supplementation alone.46 
 
STUDIES CONDUCTED ON ANEMIA 
Study done by VaniSrinivas et al Department of Community Medicine, Grant 
Medical College, JJ Hospital Campus, Byculla, Mumbai, Maharashtra, India in 2015 
showed that the overall prevalence of anaemia was 78.3%. Prevalence of mild, 
moderate and severe anemia was 64.2%, 36.2% and 0.6% respectively. 47 
 
Debjit Chattopadhyay et al in 2013 in eastern India,  showed that of the total, 
15.08 % anemic cases were less than 13 years of age i.e. paediatric age group, 7.46% 
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cases belonged to 13-18 years age group, 24.60% cases belonged to the age group of 
18 -30 years (young adults), 17.50%  cases belongs to  the age group of 30 – 40 years, 
15.29% cases belonged to 40-50 years age group, 10.8% cases belonged to 50-60 
years age group, 6.51% cases fall in the 60-70 years age group, and 2.61% cases 
belongs to old age  (greater than 70 years). The study also revealed that 1.78% cases 
had severe anaemia (Hb less than 7g% ) and 31.75% cases had mild to moderate 
anaemia(Hb 7-10g% ). And out of total anemic patients more than 87% were 
females.48 
Bharati et al in 2015 in India observed that, the highest and the lowest 
prevalence of anemia have been found to be in the central and the northeast zones, 
respectively. The vulnerable groups were the children belonging to illiterate families 
and to the low socioeconomic strata in the rural areas.49 
 
Prevalence of nutritional anemia in pregnant woman in India is a major 
problem. 33-89% among pregnant women are anemic. Among adolecent girl 60%s 
are anemic as observed by Toteja G.S et al in a study conducted in 16 districts of 
India in 2006.50 
 
The development of anemia was largely influenced by literacy, occupation, 
consumption of iron, vit B12, folate, parity, and fertility, and the Weekly 
administration of iron-folate turned out to be a practical and effective strategy for 
preventing anemia in adolescent girls. This was also seconded by K.N. Agarwal et al 
51.  
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In a study by Verma M. et al in 1998 in Punjab, prevalence of anemia was 
51.5%. Girls had a significantly higher prevalence of anemia, exception- at 5 years 
and 10-12 years age group. More menarcheal girls were anemic as compared to non-
menarcheal ones. Compared to non-vegetarians (38%), more vegetarians (65.9%) 
were anemic52.  
In a Community Based Study study conducted by Dr. Mallikarjuna M et al in 
2015 in India, the prevalence of anemia among adolescent girls was 56.3%. About 
48.3% of the normal and 45.8% of the anemic girls were aged between 10 – 13 years. 
The age of 29.1% of the adolescent anemic girls were aged between 14 – 16 years and 
24.5% were aged between 17 – 19 years. More than half of adolescent girls in this 
study belonged to Class IV socio – economic state and nuclear families53.  
 
The prevalence of anemia in children according to Zuffo CR et al in 2016 in 
Rio, was 34.7%. the major factors associated with anemia were: maternal age less 
than 28 years, male child, children less than 24 months, and children who did not 
consume iron food sources such as meat, beans, and green leafy vegetables. There 
was no significant association between anemia and iron rich food intake. 54 
 
According to Mohammad Intekhab Alam Chand et al, the prevalence of 
anaemia among adolescent girls in the year 2016 in bihar was 75.74%. The percent of 
severely, moderately and mildly anemic girls were 5.44%, 32.18%, and 38.12% 
respectively. Percentage of anemia was high in adolescent girls belonging to joint 
family as compared to nuclear family. Mean BMI of anemic girls was 17.74. The 
prevalence was maximum among adolescent girls with illiterate mothers (85.71%).55 
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The prevalence of anemia according to a study on Anemia and nutritional status of 
pre-school children in Kerala by George in 2000 was 11.4%. The percentage of 
anemic children among male and female children were 10.25 and 12.55 respectively 
and statistical analysis showed that female children were more susceptible to anemia 
than male children. Normal nutritional status was seen among 46.7% of the children. 
There was significant association between moderate under nutrition and anemia and 
undernutrition was attributed as the major reason for nutritional anemia.56 
  Among the 1000 adolescent girls included in the study conducted by 
Deshpande NS et al in 2013 in India, 60% were anemic, 18.4% had mild anemia, 
41.3% had moderate anemia, and 0.4% were having severe anaemia. The highest 
prevalence of anemia was noted among adolescent girls belonging to class III, IV, V 
of modified kuppuswamy classification and severely thin adolescent girls were found 
to be at a higher risk for developing anemia.57 
A study conducted in the three districts of orissa by bulliya G et al in 2007, 
reaveled that prevalence of anemia was high in non school going  girls. Of the total 
adolescence girls, 96.5% were anemic with 45.2% having mild, 46.9% having 
moderate and 4.4% having severe anemia58. 
According to a study on anemia and diabetes, conducted by Ranil et al, in 
Chennai in the year 2010, the prevalence of anemia in T2DM patients were  12.3%. 
Between the age 40- 49, the prevalence was higher in women than in men (26.4% v 
10.3%). Men with anemia  had double the risk of developing diabetic retinopathy than 
women. Anemia was associated with the development and progression of both 
microvascular and macrovascular complications of diabetes. Anemia also leads to a 
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falsely low HbA1c levels, which result in the under treatment of hyperglycemia and 
the progression of both microvascular and macrovascular diabetic complications59. 
Roosy Aulakh et al in the year 2009 studied the utility of red cell distribution width 
(RDW) in the diagnosis of iron deficiency among children with microcytic 
hypochromic anemia and concluded that RDW had limited specificity for diagnosis of 
Iron deficiency anemia among children with microcytic hypochromic anemia60. 
  A study carried out by  P.R. Deshmukh et al, in Maharashtra, India to study 
the ‘effectiveness’ of a weekly iron-supplementation regimen among urban-slum, 
rural, and tribal girls of the district in the year 2008 showed that the overall 
prevalence of anaemia came down significantly from 65.3% to 54.3%. The decline 
was significant in tribal girls (48.6% from 68.9%) and among rural girls (51.6% from 
62.8%).61  
Sabita Basu et al in 2005 showed that the overall prevalence of anemia (as per 
WHO Guidelines) was significantly higher among adolencent girls (23.9%) as 
compared to the opposite sex. Anemia was observed more in the rural part of India 
(25.4%) as compared to urban India (14.2%). Iron stores estimated by serum ferritin 
in the selected subjects were deficient in 81.7% of adolescent girls and 41.6% of the 
adolescent boys.62 
Kumar et al showed that the prevalence of anemia (considering anemia as Hb 
concentration <11 g/dL) was 69.6%, whereas the prevalence of iron deficiency 
anemia was 31%. The main predictors for Hb concentration were the biomarkers such 
as plasma concentrations of serum transferrin, folate, vitamin B12 among. Length-for-
age Z score and family income also predicted Hb concentration.63 
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A study on the prevalence of anaemia, conducted among the Scheduled Caste 
preschool children in the state of Punjab  in 2002 by Sidhu S et al, revealed that the 
overall prevalence of anemia was 81.66%. The prevalence of anemia was maximum 
in age group >2 and minimum in age group >5.64 
According to a community trial carried out by Jolly R et al in Vellore District, 
Tamil Nadu in 2000, the prevalence of anaemia was 44.8% with severe anaemia being 
2.1%, moderate being 6.3% and mild anaemia being 35.5%. The prevalence of 
anaemia was 40.7% in prepubertal girls compared to 45.2% in postpubertal girls. A 
significant association was found between the haemoglobin concentration and the 
girl’s and maternal literacy status.65 
  A study conducted by Sampathkumar et al in 1997, in one of the many rural 
blocks of tamil nadu in 1997 investigated the prevalence of both anemia and 
hookworm infestation in female adolescents in rural part of Tamil nadu.  The 
prevalence of anemia was found to be 76.6%. Of the total, 63% had hookworm 
infestation and 48.5% of the girls did not wear slippers when they went outside.66 
A study by Bharathi et all in 2009, that  investigated the severity and 
distribution of anemia among Indian adolescent girls of age group 10 to 19 years and 
the association of anemia with socioeconomic and demographic factors, showed that 
the highest prevalence of anemia (99.9%) was observed in Jharkhand in the eastern 
part of India. The prevalence of anemia in the northeastern states were relatively low. 
The highest prevalence rates were observed among older girls (15 to 19 years), 
illiterate girls living in rural areas, girls from illiterate households and households 
with low standard of living, girls from Scheduled Tribes and those living in west 
India, and married girls.67 




MATERIALS AND METHODS 
 
STUDY DESIGN 
 Cross-sectional study 
 
STUDY SUBJECT 
Patients attending medicine department in Sree Mookambika Institute of 
Medical Sciences,Kulasekharam. 
INCLUSION AND EXCLUSION CRITERIA 
INCLUSION CRITERIA 
 All the new patients attending in Medicine Department(outpatient and inpatient) in 
Sree Mookambika Intitute of medical Sciences with haematological problems  
 
 age group 15-85 years. 
EXCLUSION CRITERIA 
 elderly age(>85years)  
 
 any contraindication for invasive evaluation 
STUDY AREA 
Sree Mookambika Institute Of Medical Sciences 
 






18months(January 2016-june 2017) 
 
SAMPLE SIZE CALCULATION 
Sample size is calculated by using the formula  




p- Prevalance of anemia=55%(Gerardo Alvarez-Uria et al study in South India) 
q-100-p=45 
d-15% of p=15% of 55=8 
N-SAMPLE SIZE 
MINIMUM SAMPLE SIZE-154 
 SAMPLE SIZE - 160 
SAMPLING TECHNIQUE 
By convenient sampling,the patients who came to medicine department who fulfilled 
our inclusion criteria.  
PROCEDURE IN DETAIL 
ETHICAL CLEARANCE 
Clearance from the instutional ethical committee was obtained. Permission to 
conduct the study was obtained from the Head of the institute of Sree Mookambika 
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Institute of medical sciences. Informed consent was obtained from the patients who 
were included in the study. 
A brief history was obtained. The history included  socio-demographic 
factors,dietary habits,history of previous diagnosis of anemia and utilisation of health 
services for the same(blood transfusion), menstrual history,history of any bleeding 
manifestations,history suggestive of any chronic illness,history of alcohol intake and 
any  drug history. 
Data collected by laboratory investigations was to be entered on the same data 
collection tool. 
LABORATARY INVESTIGATIONS:  
All the laboratory investigations were done in CENTRAL LAB,SREE 
MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES. Blood samples were 
collected for laboratory evaluation of CBC by a trained laboratory technician. The left 
dorsum of hand was cleaned with cotton soaked in spirit and allowed to dry.With the 
help of a 3mL syringe blood is withdrawn and collected in 2 containers one for 
hematology the other for serology. 
COMPLETE BLOOD COUNT : 
 (1) Hb,PCV,TC,PLATELET,RBC,MCV,MCH,MCHC,RDW 
The blood sample collected in the red container(hematology) is allowed to mix 
properly by placing it on the mixer attached to the automated CBC machine. This 
EDTA sample is placed in an automated machine “MINDRAY BC-500” through 
which we get the complete CBC reprt in the computer connected to the machine. 
(2)ESR 
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The EDTA sample collected is kept in an automated machine “VES MATIC” 
and ESR value is obtained. 
RETICULOCYTE COUNT: 
The EDTA sample obtained is mixed with equal amounts of reticulocyte 
dilution fluid and is incubated for half an hour at 37◦C. Then a smear is made by 
taking a drop of incubated sample on a slide and holding another slide as spreader at 
an angle of 30-45◦ and sliding it forward rapidly over the slide. This smear is looked 
at with a microscope after staining it with leishman’s stain,followed by adding 
distilled water( double the amount of stain) and number of reticulocyte is counted by a 
pathologist under oil immersion lens of microscope. 
CRP: 
CRP is estimated by turbidometry method by the machine “TURBODYNE 
SC”(TULIP GROUP) .It is done by first inserting the card,and following the steps 
being shown on the machine screen,ie, first 20µL of reagent 1 is taken followed by 
20µL of blood sample and kept in incubator at 37oC for 5 minutes following which 
the incubated sample is placed in the machine and 20 µL of Reagent 2 is added and 
the value is obtained. 
PERIPHERAL SMEAR: 
Peripheral semar is done by slide method. A drop of blood is placed in the 
centre 1-2cm from one end. Another slide is used as a spreader,holding the same in 
30-45◦ near the drop of blood.The spreader is moved backwards so that it makes 
contact with the drop of blood.The spreader is then moved forward rapidly over the 
slide.A thin peripheral blood film is prepared.it is dried and then stained using 
leishman’s stain. Then distilled water is pored over the stained film doule the amount 
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of stain used.The slide is washed after 1-2 minutes,dried and examined under oil 
immersion lens of the microscope. 
SERUM IRON: 
Clotted sample is used to obtain Serum iron values by using the automated 
machine “BECKMAN COULTER”.  
SERUM FERRITIN: 
Serum Ferritin values are obtained by doing hormonal assay (CLIA method) 
by an automated machine “BECKMAN COULTER” 
SERUM TIBC: 
Clotted sample is used to obtain TIBC values by using the automated machine 
“BECKMAN COULTER”.  
STOOL:  
Stool sample is collected in a container by the patient. By card test stool is tested for 
blood,ova by using a buffering solution. 
VITAMIN B12: 
Vitamin B12 values are obtained by  hormonal assay done in an automated machine 
“BECKMAN COULTER”. 
RFT: 
Clotted sample collected is taken and serum is separated and the seperataed serum is 
passed through the automated machine “BECKMAN COULTER”. 
LFT: 
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Clotted sample collected is taken and serum is separated and the seperataed 
serum is passed through the automated machine “BECKMAN COULTER”. 
DEFINITIONS 
1.) ANEMIA 
WHO criteria was used for the diagnosis of anemia 
POPULATION NON 
ANEMIA(H
b in gms/dl) 
ANEMIA(Hb in gms/dl) 




months of age 
11 or  
higher 
10-10.9 7-9.9 <7 
Children 5-11 




11-11.4 8-10.9 <8 
Children 12-14 











11-11.9 8-10.9 <8 
Pregnant women 11 or 
higher 
 






11-12.9 8-10.9 <8 
 




2.) SOCIO ECONOMIC CLASSIFICATION  
The socio economic statuses of subjects were estimated by using modified 
B.G Prasad’s scale. The classification is based on the consumer price index 274 
during May 2017 
 
INCOME SOCIO ECONOMIC CLASS 
>6254 Upper class 
3127-6253 Upper middle class 
1876-3126 Middle class 
938-1875 Lower middle class 
<938 Lower class 
 






SOCIODEMOGRAPHIC CHARACTERISTICS  
 
AGE DISTRIBUTION 
The distribution of age in the study participants ranges from 18 to 71 years. 
The mean age of study participants were 37.88 years (95% CI is 34.998, 40.242) with 
a SD of 16.63 years. 
 








Majority of the study participants were 15-24 and 25-34 years of age group (28.8%), 
followed by 55-64 years of age group (20.6%). 
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Age distribution in the study population 
     Age Frequency Percent 
15-24 46 28.8 
25-34 46 28.8 
35-44 13 8.1 
45-54 10 6.3 
55-64 33 20.6 
65-74 12 7.5 
Total 160 100 
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GENDER 
Majority of the study participants were females (58.1%).  
Distribution of gender 
Gender Frequency Percent 
Male 67 41.9 
Female 93 58.1 
Total 160 100 
Gender of the study participants 
 
TYPE OF FAMILY 
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Distribution of type of family 
Type of family Frequency Percent 
Joint 60 37.5 
Nuclear 87 54.4 
Extended 13 8.1 
Total 160 100 
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Occupation of the study participants 
 







Skilled 25 15.6 
Semi professional 20 12.5 
Professional 10 6.3 
Total 160 100 
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SOCIO ECONOMIC STATUS 
37.5% (60) of the study participants belongs to middle class family followed by 30% 
(48) belongs to upper middle class family 
 
Distribution of socio economic status 
 
Socio Economic Status Frequency Percent 
Lower class 9 5.6 
Lower middle class 32 20.0 
Middle class 60 37.5 
Upper middle class 48 30.0 
Upper class 11 6.9 
Total 160 100.0 
 

















Lower class Lower middle
class










Socio economic st tus 
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DIET 
Most of the study participants were non vegetarians (78.1%) 
Distribution of food habits  
Food Habits Frequency Percent 
Vegetarian 35 21.9 
Non vegetarian 125 78.1 
Total 160 100.0 
 
Food habits of the study population 
 
REASON FOR BLOOD TRANSFUSION 
4.4% has taken blood transfusion due to haemorrhage and 5% has taken blood 
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Distribution of reason for blood transfusion 
Reason for Blood 
Transfusion 
Frequency Percent 
Haemorrhage 7 4.4 
Severe anaemia 8 5.0 
None 145 90.6 
Total 160 100 
 
Reason for blood transfusion in the study population 
 
EXCESSIVE BLEEDING 
13.1% (21) suffered from excessive bleeding due to upper GI bleed and only 1.9% (3) 




HAEMORRHAGE SEVERE ANEMIA NONE
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Distribution of excessive bleeding 
Excessive Bleeding Frequency Percent 
Menorrhagia 3 1.9 
Upper GI bleed 21 13.1 
No bleed 136 85.0 












MENORRHAGIA UPPER GI BLEED NO BLEED
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Yes 21 13.1 
No 139 86.9 
Total 160 100 
 
 













Distribution of chronic illness  
Chronic Illness Frequency Percent 
Yes 15 9.4 
No 145 90.6 
Total 160 100.0 
 
 














The distribution of haemoglobin in the study participants ranges from 2.5 to 17. The 
mean age of study participants were 9.8 years (95% CI is 9.242, 10.358) with a SD of 
3.6. 
 
PREVALENCE OF ANAEMIA 
58.1% (93) of the study participants were anaemic. Among them 28.1% (45) had 
moderate, 18.1% (29) had mild and 11.9% (19) severe anaemia. 
 
Prevalence of anaemia in the study population 
 
 Frequency Percent 
Normal 67 41.9 
Mild 29 18.1 
Moderate 45 28.1 
Severe 19 11.9 
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Only 60 patients was tested for CRP. Out of this 14 participants were positive for the 
test. Among them 57.1% (8) had mild anaemia and the remaining had moderate 
anaemia (42.9%) 
Prevalence of anaemia among CRP positive patients 
 
 Frequency Percent 
Mild 8 57.1 
Moderate 6 42.9 


























SEVERITY OF ANAEMIA 
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FACTORS RELATED TO ANAEMIA 
In our study there was a statistically significant association between prevalence of 
anaemia and age 
Distribution of anaemia by age 
 
Age 
                    Anaemia  
Total Anaemic 
N   (%) 
Non anaemic 
N  (%) 
15-24 15 (32.6) 31 (67.4) 46 
25-34 24 (52.2) 22 (47.8) 46 
35-44 4 (30.8) 9 (69.2) 13 
45-54 6 (60) 4 (40) 10 
55-64 32 (97) 1 (3) 33 
65-74 12 (100) 0 12 
TOTAL 93 (58.1) 67 (41.9) 160 
                  Chi-square = 52.358                   p-value = 0.001* 
       *p <0.05 is statistically significant  
 
The study revealed there was no statistically significant association between 
prevalence of anaemia and gender. 
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Non anaemic                   
N (%) 
Male 41 (61.2) 26 (38.8) 67 
Female 52 (55.9) 41 (41) 93 
Total 93 (51.8) 67 (41.9) 160 
Chi-square = 0.446                                          p-value = 0.504 
  *p <0.05 is statistically significant  
There was no statistically significant association between prevalence of anaemia and 
type of family 









Joint 38 (63.3) 22 (36.7) 60 
Nuclear 51 (58.6) 36 (41.4) 87 
Extended 4 (30.8) 9 (69.2) 13 
Total 93 (58.1) 67 (41.9) 160 
            Chi-square = 4.674                 p-value = 0.097 
  *p <0.05 is statistically significant  
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There was a statistically significant association between prevalence of anaemia and 
occupation 
 





Anaemic N (%) Non anaemic N (%) 
Unemployed 45 (54.9) 37 (45.1) 82 
Unskilled 15 (65.2) 8 (34.8) 23 
Skilled 20 (80) 5 (20) 25 
Semi 
professional 
11 (55) 9 (45) 20 
Professional 2 (20) 8 (80) 10 
Total 93 (51.8) 67 (41.9) 160 
            Chi-square = 11.694                    p-value = 0.018* 
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There was a statistically significant association between prevalence of anaemia and 
socio economic status. 
 
Socio economic   
status 
  
Total Anaemic   N (%) Non anaemic        
N (%) 
Lower class 9 (100) 0 9 
Lower middle class 23 (71.9) 9 (28.1) 32 
Middle class 37 (61.7) 23 (38.3) 60 
Upper middle class 22 (45.8) 26 (54.2) 48 
Upper class 2 (18.2) 9 (81.8) 11 
Total 93 (51.8) 67 (41.9) 160 
            Chi-square = 19.832                    p-value = 0.000* 
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There was no statistically significant association between prevalence of anaemia and 
food habits. 
 








Vegetarian 22(62.9) 13(37.1) 35 
Non 
vegetarian 
71(56.8) 54(43.2) 125 
Total 93(58.1) 67(41.9) 160 
           Chi-square = 0.412                 p-value = 0.521 











There was no statistically significant association between prevalence of anaemia and 
alcohol consumption 
 








Yes 9 (42.9) 12 (57.1) 21 
No 84 (60.4) 55 (39.6) 139 
Total 93 (58.1) 67 (41.9) 160 
            Chi-square = 2.315                                   p-value = 0.128 
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Yes 15 (100) 0 15 
No 78 (53.8) 67 (46.2) 145 
Total 93 (58.1) 67 (41.9) 160 
        Chi-square = 11.924                     p-value = 0.001* 
  *p <0.05 is statistically significant  
 
There was a statistically significant association between prevalence of anaemia and 
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Distribution of anaemia by reason for blood transfusion 
 








Haemorrhage 7 (100) 0 7 
Severe anaemia 8 (100) 0 8 
None 78 (53.8) 67 (46.2) 145 
Total 93 (58.1) 67 (41.9) 160 
            Chi-square = 12.532               p-value = 0.001* 
  *p <0.05 is statistically significant  
 
There was a statistically significant association between prevalence of anaemia and 
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Menorrhagia 3 (100) 0 3 
Upper GI 
bleed 
21 (100) 0 21 
No bleed 69 (50.7) 67 (49.3) 136 
Total 93 (58.1) 67 (41.9) 160 
            Chi-square = 24.091                p-value = 0.000* 








The overall prevelance of anemia in our present study was found to be 58.1% 
of which 28.1% has moderate,18.1% has mild and 11.9% has severe anemia.A lower 
prevelance of anemia(35.1%) was noted by Sanjeev M Chaudhary et al68. The study 
done by the same, had none who was suffering from severe anemia.A higher 
prevelance of anemia was noted by J.Rajaratnam et al in Tamil Nadu69. Toteja.G.S et 
al found 90% prevelance of anemia among adolescent girls in 16 distriucts of 
India,with 7.1% having severe anemia.50 
 
The highest prevelance of anemia was seen in the age group of 55-64 years in 
our study ie,34.4% of the total anemic patients,while a study done by Gerardo 
Alvarez-Uria Et al  found that the most commonly affected age group with anemia is 
in those less than 10 years, especially in those less than 5 years followed by women 
and older adults70.Another study done by Sanjay Gupta et al  found a high number 
42% of anemia cases in the age group of 11-25 years.71 
 
In our study there was no statistical significant association of anemia with 
gender. In our study it was found that out of the total patients with anemia majority 
were females,55.9%.Likewise in a study done by Sanjay Kumar Gupta et al, among 
the cases of anemia 82% was females and 18% affected was males71.In another study 




males-52.21%  and moderate and severe anemia was more common among females- 
50.98% and 51.67% respectively.72 
The majority of subjects with anaemia in the present study has microcytic 
hypochromic picture in peripheral smear; suggestive of iron deficiency anemia while 
20.4% of the anaemic people have dimorphic picture. Sanjeev M Chaudhary et al also 
found majority of subjects with anaemia (25.4%) had microcytic hypochromic picture 
while 4.7% had dimorphic picture in peripheral smear68. Whereas Khandhuri et all 
found peak incidence of megaloblastic anemia in the age group of 10-30 years 
old(48%)74. 
 
The high prevalence of anemia in child bearing age group is of important 
public health indication. It is found that anemia accounts for 12.8% of Maternal 
mortality in Asia75.Iron requirements are more in pregnancy and iron deficiency is 
associated with low birth weight,pre-term delivery and maternal death.76 
 
There was significant association between anemia and chronic illnesses. In our 
study all the 15 patients who were suffering from a chronic illness was found to have 
anemia,ie a 16% of the total anemic patients. The basic pathology behind it being 
decreased availability of iron,decrease in life span of RBC from 120 days to 70-80 
days,and erythropotein deficiency.77 Out of the 15 patients,12 were CKD patients.  
The study done by Obrador et al showed that 88% of those with advanced stages of 
CKD who required renal replacement therapy had a PCV less than 30mg/dl.78 Anemia 
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PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Volunteers, 
      We welcome you and thank you for your keen interest in participating in this research 
project. Before you participate in this study, it is important for you to understand why this 
research is being carried out. This form will provide you all the relevant details of this 
research. It will explain the nature, the purpose, the benefits, the risks, the discomfort, the 
precautions and the information about how this project will be carried out. It is important that 
you can read and understand the contents of the form carefully. This form may contain 
certain scientific terms and hence, if you have any doubts or if you want more information, 
you are to ask the study personnel or the contact person mentioned below before you give 
your consent and also at any time during the entire course of the project. 
1. Name of the Principal Investigator :  Dr.Jineesh Raj 
   Postgraduate-M.D General Medicine 
   SMIMS, Kulasekharam 
   Mob:9585953436 
   Email-drjineeshraj@gmail.com 
2. Name of the Guide      :   Dr.K Krishnan kutty. 
   Associate Professor  
   Department of Medicine 
   SMIMS, Kulasekharam 
   Mob No: 9443404424 
   Email: kuttykrish@yahoo.co.in 
3. a. Name of the co-guide :   Dr.R V Mookambika 
      Asst Professor 
   Department of Medicine 
   SMIMS, Kulasekharam 




   Email: drmookambika86@gmail.com  
4. Institute: details with Address :   Sree Mookambika Institute Of  
                                                                           Medical Science 
  Kulasekharam, 
                                                     Kanyakumari District-629161 
                        Tamil Nadu 
5. Title of the study:   
“Prevalence and etiology of anaemia in tertiary care hospital in kanyakumari 
district”. 
 
6. Background Information: 
Hematological disorder include non malignant like various anaemia, bleeding 
disorder, plateletdisorder,hemoglobinopathies malignant include leukemia, lymphoma, 
plasma cell dyscrasia,myeloproliferativeneoplasm.The prevalence of anaemia is 
disproportionately high in developing countries like India. It has mainly been ascribed to 
poverty, inadequate diet, certain diseases, pregnancy and lactation, and poor access to 
health services in developing countries. Nutritional anaemia constitutes the most 
important cause of anaemia. It is mainly due to deficiency of Iron, Vitamin B12 and 
Folate. Young people are particularly susceptible to develop anaemia because of their 
rapid growth and associated high iron requirements. This study aims at finding the 
prevelance of anaemia and the possible causes which helps in the management of 
anaemia. 
7. Aims and Objectives: 
1.To study the prevalence of anaemia and its aetiology in patients attending Sree 
Mookambika Institute Of Medical Science. 
2.To find out the proportion of patients with nutritional anaemia. 









Early detection of the same has a better prognosis and brings out a better outcome. 
In India, the prevalence of anaemia is high because of   
 Low dietary intake, poor iron (less than 20 mg /day) and folic acid intake (less than 70 
micrograms/day) 
 Poor bio-availability of iron (3-4 percent only) in phytate fibre-rich Indian diet  
 Chronic blood loss due to infection such as malaria and hookworm infestations 
 
  
10. Procedure of the study: 
After acceptance of thesis by the ethics committee an informed consent will be obtained from 
those patients who have abnormal bloodcount parameters,visiting to  SMIMS. 
History taking performa is used for documenting age/sex/address/clinical 
information/symtoms/predisposing factors,drug history,socioeconomic status and previous 
history of treatment. 
Investigation-Complete Blood Count(CBC),peripheral smear,reticulocyte 
count.Results will be analysed and further relevant investigations will be done as per 
the proforma. 
 
All data collected will be charted and analysed to find the aetiology and prevalence of 
anaemia,also the proportion of nutritional anaemia wil be obtained. 
11.Expected risk of the participants: There are no expected adverse events or risks. 
 
12.Expected Benefits of the Research for the participants:  direct benefit available to 
participants is early detection of the disease.once the patients are detected of various 
disorders treatment plan can be started at the earliest. 
 
13.Maintenance of confidentiality: All data collected for the study will be kept 
confidentially. No personal details will be revealed. 
14.Why have I been chosen to be in this study:  you have abnormal values of blood counts 
which needs evaluation.So you  fulfil the criterion for selection. 
15.How many people will be in the study :  154 




17.Anticipated prorated payment, if any, to the participants of the study : Nil 
18.Can I withdraw from study at any time during the study period :  Yes 
19.If there is any new finding/information, would I be informed :  Yes 
20.Expectedduration of the participantsparticipation in the study : 12 months 
21.Whom do I contact for further information   : 
 
For any study related queries,you are free to contact 
Dr Jineesh Raj 
Post Graduate – M.D General Medicine 
Department of General Medicine 
SreeMookambika Institute of Medical Sciences, 
Kulasekharam, Tamil Nadu -629161 




Place:                            
Date: 











CONSENT  FORM 
PART 2 OF 2 
PARTICIPANTS CONSENT FORM 
The details of the study have been explained to me in writing and details have been 
fully explained to me. I am aware that the results of the study may not be directly beneficial 
to me but will help in the advancement of medical sciences. I confirm that I have understood 
the study and had the opportunity to ask questions. I understand that my participation in the 
study is voluntary and that I am free to withdraw at any time, without giving any reasons, 
without the medical care that normally is provided by the hospital being affected. I agree not 
to restrict the use of any data or results that arise from this study provided such a use is only 
for scientific purpose(s). I have given details of the study. I fully consent to participate in the 
study titled “Prevalence and Etiology of anaemia in tertiary care hospital in 
kanyakumari district.” 
Serial no/Reference no: 
Name of the participant:                                                       
Address of the Participant: 
Contact number of the Participant: 
                                        Signature/Thumb impression of the participant/Legal guardian 
  Witness 
       1. 
       2. 








k½X ]{Xw þ `mKw þ 1 
]T\hpambn klIcn¡p¶ hyànIfpsS Adnhntebv¡v 
{]nbs¸« k¶² tkhItc, 
 R§Ä \n§sf kzmKXw sN¿p¶p.  AtXmsSm¸w Cu ]T\hpambn klIcn¡m\pÅ k¶²XtbmSv 
\μn tcJs¸Sp¯p¶p.  \n§Ä Cu ]T\¯nÂ ]s¦Sp¡p¶Xn\p ap³]v Cu ]T\w  F´n\mWv 
\S¯s¸Sp¶Xv F¶v Andtb−Xp−v. AXn\mÂ Cu t^md¯nÂ  KthjW ]T\¯nsâ hnhc§fpw aäpw  
hniZambn tcJs¸Sp¯nbncn¡p¶p.  Cu ]T\¯nsâ coXn, Dt±iw, {]tbmP\w, A]ISkm²yX, t¢iw, 
ap³IcpXÂ, F§s\ Cu ]T\w ap³t]m«p sIm−pt]mIp¶p F¶n§s\  FÃm hnhc§fpw t^md¯nÂ  
tcJs¸Sp¯nbn cn¡p¶p.  kZbw Cu  hnhc§Ä  hmbn¨p a\Ênem¡phm³  A`yÀ°n¡p¶p.  Cu 
hnhc§fnÂ imkv{X]camb ]Z§Ä DÅXn\mÂ  kwib\nhmcW¯n\p {][m\ ]T\IÀ¯mhnt\mtSm Xmsg 
tcJs¸Sp¯n bncn¡p¶ hyànItfmtSm t^mdw H¸nSp¶Xn\p ap³t]m AsÃ¦nÂ Cu ]T\¯nsâ Imemh[n 
Xocp¶Xphtctbm kao]n¡mhp¶XmWv.  
1. kq{X[mc³   :  tUm.Pnt\jv cmPv 
    _ncpXm\´c _ncpX hnZymÀ°n, 
P\dÂ saUnkn³ hn`mKw 
    {io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kv, 
    IpetiJcw þ 629 161. 
   
2. {][m\ amÀ¤ZÀin  : tUm.IrjvW³ Ip«n  
s{]m^kÀ   
P\dÂ saUnkn³ hn`mKw, 
{io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kkv, 
IpetiJcw. 
      
 
3. kl amÀ¤ ZÀin  : tUm. aqImw_nI 
hr¡ hn`mKw, 
{io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kkv, 
IpetiJcw. 
 
4. C³Ìnäyq«v  : {io. aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â kb³kkv 
    ]S\new, IpetiJcw, I\ymIpamcn þ 629 161. 
    Xangv\mSv.  
 
5.  ]T\ hnjbw:  
 
I\ymIpamcn PnÃbnse {XnXob Bip]{XnIfnÂ hnfÀ¨ km[yXbpsS B[nIyhpw, AhbpsS 
ImcW§fpw. 
 
6.  ]T\ ]mÝm¯ew? 
 
  càtcmK§sf c−mbn Xcw Xncn¡mw.  Iym³kÀ, Iym³kÀ AÃm¯h,  Iym³kÀ AÃm¯ 
càtcmK§Ä ]eXcap−v.   ]ebn\  hnfÀ¨IÄ  »oUnwMv AkpJ§Ä , lotamt¥m_nt\m ]Xnbkv, 
Iym³kÀ Xs¶ ]eXcap−v. càmÀ_pZw, IgeIÄ, ¹mkamskÂ Unkvt{Imknb abntemt{]men^ntdänhv 
AkpJ§Ä . 
 hfÀ¨ F¶Xv hnIkzc cmPy§fnÂ IqSpXembn  ImWp¶p F¶mWv.  AXn\v  ImcWambXv 
Zmcn{Zyhpw, tcmKmhØIfpw, `£WIpdhpw, KÀ`w, apebq«Â  tcmKmhØsb Xncn¨dnªv  NnInÕn¡p¶p.  
kabIqSpXep F¶nhsbÃmamWv.  t]mjI Blmc§fpsS  IpdhmWv hnfÀ¨bpsS Hcp {][m\ ImcWw.  




hnfÀ¨bp−mIpw.  bphP\§fnÂ  hnfÀ¨ A[nIambn  I−phcp¶XpImcWw AhcpsS  hfÀ¨bv¡v  
AXymhiyamb Ccp¼p k¯v  In«p¶nÃ. 
 càmÀ_pZ¯nÂ c−p Xcamb  AML, ALL F¶nhbnÂ AML A[nIamb ]¯v hbÊn\ptaÂ 
{]mbapÅhcnÂ Is−¯pIbpw  AL F¶ AhØ 65 hbÊn\v taepÅhcnÂ  A[nIambn ImWs¸Sp¶p.  
]c¼cmKXamb AkpJ§Ä , tdUntbj³, NpäpapÅ A´co£w , acp¶pItfmSpÅ kmao]yw hbdÊpIÄ  
F¶nhbmWv càmÀ_pZ¯n\v {][m\ ImcW§Ä.   
7.  e£y§Ä  
 
1. {io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â kb³knse hnfÀ¨ km[yXbpÅ tcmKnIfnÂ  
AXnsâ 
  B[nIyhpw, ImcW§fpw Xncn¨dnbm\pÅ ]T\w. 
2. t]mjI Blmc IpdhpsIm−p−mIp¶ hnfÀ¨bpsS A\p]mX¯nsâ ]T\w. 
8.  ]T\s¯¡pdn¨pÅ imkv{Xob \ymboIcWw 
 
¾ C´ybnÂ, hnfÀ¨bpsS hym]vXn IqSpXemWv AhbpsS ImcW§Ä  
¾ `£W¡pdhv, Ccp¼pk¯v Ipdhv  (< 20 Fw.Pn/ Znhkhpw) IqSmsX t^mfn¡v BknUv Ipdhv 
(< 70Fw.Pn/ Znhkhpw) 
¾ C´y³ `£W coXnbnÂ  Ccp¼p k¯v  3þ4 iXam\w am{Xta DÅp. 
¾ ae¼\n sImt¡m¸pgp F¶o tcmK§Ä  ImcWapÅ cà¡pdhv. 
Cu ]T\¯neqsS hnfÀ¨bpsS hym]vXn {io aqImw_nIm saUn¡ÂtImtfPnse tcmKnIfnÂ 
F{Xam{Xw  F¶v Is−¯pI F¶XmWv Dt±iw 
9.  ]T\coXn 
 Cu ]T\w {io aqImw_nI C³Ìnäyq«nÂ  h¨mWv \S¯p¶Xv. BhiyapÅ hnhc§Ä  
tcmKnIfnÂ \n¶pw  tiJcn¡p¶XmWv.  
 
 tcmKnbpsS hbÊpw, taÂhnemkhpw, tcmKhnhc§fpw A]IS LSI§fpw , NnInÕm 
hnhc§fpw Ipdn¨p hbv¡p¶p.  
 
 ]cntim[\IÄ  càtImi AfhpIÄ aÖbnÂ Ip¯nsbSp¯v ]cntim[n¡pI, DZc¯nsâ 
kvIm³, Ccp¼nsâ ZmXpIfpsS ]T\w. 
 
10.  ]T\w aqew ]s¦Sp¡p¶ BÄ¡v D−mIm³ CSbpÅ A]IS km[yX ?    H¶panÃ 
 
11. ]T\w aqew ]s¦Sp¡p¶ BÄ¡v D−mIp¶ t\«w  ? 
 
hfsc  t\ct¯ tcmKnbpsS  tcmKmhØ Is−¯pIbpw  Ahsb Xncn¨dnªv t\ct¯ 
Xs¶ NnInÕmcoXn XpS§m\pw km[n¡pw.  
12.  hnhc§Ä clkyambn kq£n¡p¶pt−m  ?  




13.  Cu ]T\¯nÂ \n§sf XncsªSp¡p¶sX´n\v ? 
cà]cntim[\bnÂ AfhpIÄ¡v  hyXymkapÅXn\mÂ  AXns\ hnebncpt¯−XmWv. 
14.  F{X BfpIÄ Cu ]T\¯nÂ DÄs¸Sp¶p.    154 
 





16.  ]s¦Sp¡p¶hÀ {]Xo£n¡p¶ XpI     þ CÃ 
 
17.  Ft¸mÄ thWsa¦nepw  F\n¡v  Cu ]T\¯nÂ \n¶v  ]n·mdmtam?- þAtX 
 
18.  Cu KthjW¯nsâ ^eambn ]pXnb Fs´¦nepw  Is−¯epIfps−¦nÂ AXv 
Fs¶ Andbn¡ptam ?   
       XoÀ¨bmbpw, Cu ]T\¯nsâ Is−¯epIÄ Cu ]T\mhkm\w \n§sf 
Adnbn¡p¶Xmbncn¡pw. 
19.  Cu ]T\¯nsâ  kab ssZÀLyw F{XbmWv ?   12þ18 amkw hsc  
20.  thsd GsX¦nepw hnhc§Ä ? CÃ 
21.   IqSpXÂ  hnhc§Ä¡mbn Xmsg ]dbp¶hsc \n§Ä¡v  _Ôs¸Smhp¶XmWv. 
 
    tUm.Pnt\jv cmPv 
    _ncpXm\´c _ncpX hnZymÀ°n, 
P\dÂ saUnkn³ hn`mKw 
    {io aqImw_nI C³Ìnäyq«v Hm^v saUn¡Â  kb³kv, 
    IpetiJcw þ 629 161. 
                samss_Â \¼À : 9585953436 
    CþsabnÂ sFUn: drjineeshraj@gmail.com 
 
Øew:  IpetiJcw          apJy KthjIsâ  H¸v 
 


















`mKw þ 2 
 
 Cu ]T\s¯¡pdn¨pÅ hniZmwi§Ä Fgp¯paqeambn Fs¶ Adnbn¨p«p−v.  F\n¡v 
Cu ]T\w sIm−v t\cn«p KpWw CsÃ¦nepw  CXv saUn¡Ä kb³kn\v hfsc KpWIcamb  H¶mWv.  
F\n¡v  ]T\w ]qÀ®ambn a\ÊnembXn\mÂ  Rm³ kzbw Cu ]T\¯nÂ  ]¦ptNcpIbmWv.  GXp 
kab¯pw  F\n¡v  CXnÂ \n¶pw  ]n³amdm\pÅ AhImiw DÅXmbpw F¶v F\n¡v  
t_m[ys¸«ncn¡p¶p.  AsXsâ  NnInÕbnÂ  GXphIbnepw  XSÊamIm³ ImcWamhpIbpanÃ. Cu 
]T\¯nÂ  \n¶papÅ ^e§Ä  hnÚm\]cambn  am{Xambn  D]tbmKn¡p F¶pÅXpw  F\n¡p  
t_m[yambn.  Cu ]T\¯ns\¡pdn¨pÅ apgph³  tcJIfpw  AS§nb  ]{Xw  F\n¡p e`n¨p.   
Rm³ “I\ymIpamcn PnÃbnse {XnXob Bip]{XnIfnÂ hnfÀ¨ km[yXbpsS B[nIyhpw, AhbpsS 
ImcW§fpw.” At\zjW¯nÂ Rm³ ]qÀ®ambpw  k½Xn¨psIm−v ]s¦Sp¡p¶p.   
 
kocnbÂ \¼À / d^d³kv \¼À : 
]s¦Sp¡p¶ Bfnsâ t]cv : 
taÂhnemkw : 
 
                H v¸ / hnceSbmfw 
km£n :   




















gFjp – 1 
Ma;tpy; gq;FngWNthUf;fhd jfty;fs; 
md;ghh;e;j jd;dhh;tyh;fNs! 
 vq;fs; Ma;tpy; jhq;fs; Mhptj;Jld; gq;Nfw;wikf;F ed;wp $wp 
tuNrw;f;fpNwhk;. ,jpy; fye;J nfhs;tjw;F Kd; ,e;j Ma;T vjw;fhf elj;jg;gLfpwJ 
vd mwpe;jpUf;f Ntz;baJ Kf;fpakhFk;.  ,e;j gbtj;jpy; jq;fSf;F Njitahd 
midj;J jfty;fSk; ,Uf;fpwJ. ,e;j Ma;tpd; jd;ik> Njit> ed;ikfs;> 
Mgj;Jfs; Mfpait ,e;j gbtj;jpy; mlq;Fk;.  ,e;j gbtj;jpy; mwptpay; rhhpe;j 
thh;j;ijfs; ,Ug;gjhy;> jq;fs; re;Njfq;fis Ma;tpd; ve;j Neuj;jpYk; fPNo 
Fwpg;gpl;Ls;s eghplk; Nfl;L njhpe;Jf;nfhs;syhk;.  
1. Kjd;ik Ma;thshpd; ngah; : lhf;lh;. [pdP\; uh[;  
KJfiy nghJ kUj;Jtk; 
_ Kfhk;gpfh kUj;Jt fy;Y}hp 
kUj;Jtkiz 
FyNrfuk; 
miyNgrp vz;: 9585953436 
kpd;dQ;ry; - drjineeshraj@gmail.com 
2. topfhl;bapd; ngah;  : lhf;lh; fpU\;zd; Fl;b 
Nguhrphpah; 
kUj;Jtj;Jiw 
_ Kfhk;gpfh kUj;Jt fy;Y}hp 
kUj;Jtkiz 
FyNrfuk; 
miyNgrp vz;: 9447043863 
kpd;dQ;ry; - vkumardr@yahoo.co.in 
3. Jiz topfhl;bapd; nghah; : lhf;lh;. %fhk;gpfh 
,iz Nguh~phpah;  
kUj;Jtj;Jiw  
_ Kfhk;gpfh kUj;Jt fy;Y}hp 
kUj;Jtkiz 
FyNrfuk; 






4. fy;Y}hpapd; ngah;        : _ Kfhk;gpfh kUj;Jt fy;Y}hp  
kUj;Jtkiz FyNrfuk; 
fd;dpahFkhp khtl;lk; - 629161 
jkpo;ehL. 
 
5. Ma;tpd; jiyg;G   :
  
 
6. gpd;dzp jfty;fs;: 
,e;jpah Nghd;w tsUk; ehLfspy; ,wj;j Nrhifapd; msT mjpfkhfp 
tUfpwJ.  ,we;j tWik> rhpahd cztpd;ik> rpy Neha;fs;> fh;gk;> jha;g;ghy; 
nfhLj;jy; kw;Wk; rhpahd kUj;Jt trjpfs; ,y;yhky; ,Uj;jy;> czT 
Fiwg;ghl;lhy; tUk; ,uj;jNrhifNa kpf Kf;fpakhd fhuzkhf mikfpwJ.  
,Uk;G rj;J> B12  caph;rj;J> HNghNyl; Kjypa FiwghLfNs Kf;fpakhdit 
MFk;. ,w;j Ma;thdJ ,uj;jNrhif Vw;gLk; tpfpjj;ijAk; mjd; 
fhuzj;ijAk; mwpaNt gad;gLfpwJ. 




8. Ma;tpd; mwptpay; tpsf;fk;: 
 ,e;jpahtpy; ,uj;j Nrhifapd; tpfpjk; kpf mjpfk; Vnddpy;>  
¾ czT Fiwthf vLj;Jf;nfhs;Sjy;> ,Uk;Grj;J kw;Wk; HNghypf; 
mkpyr;rj;J FiwghL (70 mrg – f;Fk; Fiwthf) 
¾ Fiwe;j igNah mitygypl;b - ,Uk;G ehh;rj;J 
¾ kNyhpah kw;Wj; nfhf;fpGO njhw;W fhuzkhf Vw;g;gLk; ,uj;j ,og;G 
9. Ma;tpd; nra;Kiw  
10. gq;F ngWNthh;fspd; vjph;ghh;f;fh;hLk; Mgj;J : Ve;j Mgj;Jk; ,y;iy 
11. gq;F ngWNthh;fspd; ed;ikfs;  : Nehia rPf;fpuk; fz;lwpayhk;. Nehia 
rPf;fpuk;  





12. Ma;tpd; ,ufrpaj;jd;ik  : Ma;tpy; Nrfhpf;fg;gLk; jfty;fs; 
midj;Jk;  
 ,ufrpakhf ghJfhf;fg;gLk;. 
13. ehd; Vd; ,e;j Ma;tpw;F Njh;njLf;fg;gl;Nld; :  
Njh;e;njLg;gjw;f;fhd jFjpfis wPq;fs; G+h;j;jp nra;fpwhh;fs;. 
14. Ma;tpy; ngWNthh;fspd; vz;    : 154 
15. ngWNthh;fSf;F toq;fg;gLk; xg;ge;jk;  : ,y;iy 
16. ngWNthh;fSf;F VNjDk; njhif toq;fg;gLkh : ,y;iy 
17. Ma;tpd; NghJ ehd ve;jNeuKk; tpyfpf;nfhs;syhkh : Mk; 
18. VNjDk; GJ jfty;fs; fpilj;jhy; njhptpf;fg;gLkh? : Mk; 
19. Ma;T elj;jg;gLk; Neuk; : 12-18 khjq;fs; 
20. VNjDk; jfty;fs;  : ,y;iy 
21. NkYk; jfty;fSf;F ahiu mZf Ntz;Lk; : lhf;lh;. [pdP\; uh[;  
  KJfiy nghJ kUj;Jtk; 
     _ Kfhk;gpfh kUj;Jt fy;Y}hp       
  kUj;Jtkiz. FyNrfuk; 















gFjp – 2 
gq;Nfw;ghsh; xg;Gjy; gbtk; 
 Ma;T Fwpj;j jfty;fs; vOj;jpd; %yk; vdf;F njhptpf;fg;gl;lJ. 
Ma;tpd; KbTfs; Neubahf vdf;F ve;j ed;ikAk; jug;Nghtjpy;iy 
vd;gij mwpNtd;. Ma;T Fwpj;J KOtJk; mwpe;Jnfhz;Nld;. Ma;tpd; 
ve;Neuj;jpYk; ehd; tpyfpf; nfhs;syhk; vd;gij mwpNtd;. Mwptpay; 
fhuzq;fSf;fhfNt ,e;j Ma;T elj;jg;gLfpwJ vd;gijAk; mwpNtd;. 
“= %fhk;gpfh kUj;Jt fy;Y}hp kUj;Jtkid Nehahspfspy; ,uj;j 
rk;ge;jkhd Neha;fspd; tpfpjk;.  
thpir vz; : 
gq;Nfw;ghshpd; ngah; :     
gq;Nfw;ghshpd; Kfthp : 
 
 

















AGE :                                               SEX: 
OCCUPATION:                                        PLACE: 
DIET HABBITS:                                               
HISTORY OF BLOOD TRANSFUSIONS: 
REASON FOR TRANSFUSION: 
HISTORY OF EXCESSIVE BLEEDING: 
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2) Sex: Male (1) 
            Female(2) 
3) Occupation: Unskilled(1) 
      Skilled(2) 
      Semi-professional(3) 
      Professional(4) 




5) Dietary Habit: VEGETARIAN (1) 
               NON VEGETARIAN(2) 
 
 
6) History of blood transfusion:  HAEMORRHAGE(1) 
             THALASSEMIA(2) 
             SEVERE ANEMIA(3) 
             NONE(4) 
7) History of excessive bleeding: MENORRHAGIA(1) 
      UPPER GI BLEED(2) 
               LOWER GI BLEED(3) 
   OTHER BLEEDING 
   MANIFESTATION(4) 






8) History  of alcohol intake: YES(1) 
           NO(2) 
 
 
9) Chronic illnesses:   YES(1) 
               NO(2) 
10) Drug history:   YES(1) 
         NO(2) 
11) Hb: HAEMOGLOBIN 
12) TC: TOTAL COUNT 
13) PLATELET COUNT 
14) MCV: MEAN CORPUSCULAR VOLUME 
15) MCH: MEAN CELL HEMOGLOBIN  
16) MCHC: MEAN CORPUSCULAR HEMOGLOBIN  
          CONCENTRATION 
17) RDW: RED CELL DISTRIBUTION WIDTH 
18) PERIPHERAL SMEAR:   
 NOT DONE(0) 
  MICROCYTIC HYPOCHROMIC(1) 
   MACROCYTIC HYPOCHROMIC(2) 
   NORMOCYTIC NORMOCHROMIC(3) 
   DIMORPHIC (4) 
   LEUKEMIC AND OTHERS(5) 
19) RETICULOCYTE COUNT 
20) RED BLOOD CELL COUNT 
21) ESR:ERYTHROCYTE SEDIMENTATION RATE 
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